Abstract
Between 1982 and 1991, 41 patients were treated for non HIV related primary cerebral lymphoma (PCL) in our institute. The purpose of this study was to perform a multivariate analysis of prognostic factors for survival in these patients. The presence of a CSF protein level over 0.6 g l-1 at diagnosis was found to be the most significant unfavourable prognostic factor in univariate analysis and had not previously been reported. Among the five significant prognostic factors at diagnosis, (age over 60 years, performance status--ECOG scale--over 2, memory dysfunction, non hemispheric tumour site, CSF protein level over 0.6 g l-1 at the diagnosis), three independent factors were identified in multivariate analysis: (1) CSF protein level (P = 0.007; RR = 4.7); (2) PS > 2 (P = 0.04, RR = 2.65); (3) age over 60 (P = 0.08; RR = 2.43). Using the regression coefficient of these three parameters, we determined a prognostic index which allowed us to distinguish three risk groups whose theoretical median survival is 4, 20 and 54, months respectively in patients with non HIV related PCL. These results indicate that PCL is an heterogeneous disease in terms of the prognostic in which three subgroups with discriminant survival can be identified.
MeSH Terms
Adolescent
Adult
Age Factors
Aged
Brain Neoplasms/diagnosis,therapy
Cerebrospinal Fluid Proteins/analysis
Female
Humans
Lymphoma/diagnosis,therapy
Male
Memory/physiology
Middle Aged
Multivariate Analysis
Prognosis
Radiotherapy Dosage
Risk Factors
Survival Analysis
Chemicals
Cerebrospinal Fluid Proteins
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Blay J Y
Department de Chimiothérapie massive et de greffe de moëlle, Centre Léon, Berard, France.
Lasset C
Carrie C
Chauvin F
Coiffier B
Gisselbrecht C
Clavel M
Rebattu P
Brunat-Mentigny M
Philip T
References (26)
26 references, click to expand
-
Primary lymphomas of the central nervous system: patterns of failure and factors that influence survival.
J Clin Oncol. 1985 Apr;3(4):490-4
PMID: 3981223
-
Primary lymphoma of the central nervous system. Computerized tomography scan characteristics and treatment results for 12 cases.
Cancer. 1983 Dec 1;52(11):1993-2000
PMID: 6354420
-
Primary non-Hodgkin's lymphoma of the brain. A review.
Medicine (Baltimore). 1985 Nov;64(6):425-30
PMID: 4058305
-
Primary malignant lymphoma of the central nervous system.
Cancer. 1986 Sep 1;58(5):1106-11
PMID: 3089578
-
Developments in the diagnosis and treatment of primary CNS lymphoma. A prospective series.
Cancer. 1986 Oct 15;58(8):1609-20
PMID: 3756785
-
Primary malignant lymphoma of the central nervous system. Results of treatment of 11 cases and review of the literature.
J Neurosurg. 1986 Nov;65(5):600-7
PMID: 3772445
-
Primary central nervous system lymphoma.
J Neurosurg. 1988 Jun;68(6):835-53
PMID: 3286832
-
Increasing incidence of primary brain lymphoma in the US.
Cancer. 1988 Dec 1;62(11):2461-5
PMID: 3179963
-
Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma.
Cancer Res. 1988 Dec 15;48(24 Pt 1):7310-3
PMID: 3056613
-
Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma.
Cancer. 1989 Mar 1;63(5):939-47
PMID: 2914300
-
LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma.
J Clin Oncol. 1989 Aug;7(8):1018-26
PMID: 2474057
-
Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy.
Neurology. 1990 Jan;40(1):80-6
PMID: 2296388
-
Management of primary cerebral lymphoma with initial chemotherapy: preliminary results and comparison with patients treated with radiotherapy alone.
Int J Radiat Oncol Biol Phys. 1990 Apr;18(4):787-92
PMID: 1691160
-
Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine-doxorubicin-cyclophosphamide-prednisolone chemotherapy.
Cancer. 1990 May 1;65(9):1907-12
PMID: 2372761
-
Primary central nervous system lymphoma: analysis of prognostic variables and patterns of treatment failure.
Radiology. 1990 Sep;176(3):855-60
PMID: 2389047
-
High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children.
J Clin Oncol. 1991 Jan;9(1):123-32
PMID: 1985161
-
Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial.
J Clin Oncol. 1991 Jan;9(1):25-38
PMID: 1702144
-
Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function.
J Clin Oncol. 1991 Sep;9(9):1580-90
PMID: 1875220
-
Combined modality therapy for primary CNS lymphoma.
J Clin Oncol. 1992 Apr;10(4):635-43
PMID: 1548527
-
Primary malignant lymphomas of the central nervous system.
Cancer. 1974 Oct;34(4):1293-302
PMID: 4607602
-
A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group.
Eur J Cancer. 1979 Aug;15(8):1033-41
PMID: 510341
-
CNS involvement in the non-Hodgkin's lymphomas.
Cancer. 1980 Feb;45(3):545-52
PMID: 6986199
-
Radiation therapy in the management of primary malignant lymphoma of the brain.
Int J Radiat Oncol Biol Phys. 1981 Jan;7(1):55-9
PMID: 7263339
-
Primary lymphoma of the central nervous system.
Cancer. 1982 Mar 1;49(5):939-43
PMID: 7059928
-
Primary non-Hodgkin's lymphoma of the central nervous system. Results of radiotherapy in 15 cases.
Cancer. 1983 Jun 1;51(11):2048-52
PMID: 6839294
-
Primary central nervous system lymphoma in homosexual men. Clinical, immunologic, and pathologic features.
Am J Med. 1985 May;78(5):742-8
PMID: 3873174